Nephrology

Higher ultra-processed food intake is linked to increased clinical weakness in hemodialysis patients, new research shows.

A new study suggests that sustained higher BMI may reduce cardiovascular risk in chronic kidney disease, challenging traditional weight management approaches.

Stopping RAS inhibitors after an eGFR decline may increase risk of kidney failure and death, according to a large cohort study.

Novel urinary biomarkers could improve CKD risk stratification by capturing tubular injury and repair beyond traditional albuminuria measures.

A new study identifies key predictors of successful renal replacement therapy weaning and introduces a bedside tool to guide ICU decision-making.

Greater chronic kidney disease severity, particularly proteinuria, is linked to increased risk of cognitive impairment, a large cohort study finds.

RAAS inhibitors reduce kidney failure risk and improve blood pressure control compared with calcium channel blockers in children with CKD, new real-world data show.

Interim results from the Phase III VISIONARY trial show that sibeprenlimab significantly reduced proteinuria and improved disease biomarkers in patients with IgA nephropathy.